Funding

PART B: VALORISATION PLAN

SECTION I: ESTIMATION OF COSTS

 

1

Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result.
In this section we expect an analysis of funding needed or expected for valorization of the R&D result. An estimation is expected (range of costs not obviously exact amounts)
… in terms of IPR protection
In this case the R&D result is a hardware and software’s system, so it need a  protection. In order to evaluate the protection needs, a prior-case assessment to the identification of innovative technologies could be done (for example by the PatLib network, established in Area Science Park).This analysis does not provide significant costs, while the cost of a patent in Italy is about 2.500 €.

 

…in terms of product development
In terms of product development, AVIRES team needs a software developer for 6 months (18.000 €) 

 

…in terms of mass production
There are not specific mass production costs 

 

… in terms of marketing
At the moment, the marketing costs are not predictable. 

 

 

2

Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs

Year 1

Year 2

Year 3

Year 4

Year 5

Fixed costs

n.a.

n.a.

n.a.

Personnel

n.a.

n.a.

n.a.

Other running costs

n.a.

n.a.

n.a.

Marketing costs

n.a.

n.a.

n.a.

TOTAL EXPECTED COSTS

Price per Unit

n.a.

n.a.

n.a.

Type of Unit

Number of Units

TOTAL Expected Revenues

CASH FLOW REQUIRED (REVENUES-COSTS)

TOTAL CAPITAL required for five years

 

SECTION 2: QUALITATIVE FACTORS

 

4

Dimension of identified target groups
An estimation of the proportion of the target market (described in Section 3) which we expect to take
AMOS is addressed to companies working in assembly lines or to companies working in risky industrial environments (i.e. oil and gas industries, chemical manufacturing industries, …).

The system can be also used as a means of preventing workplace accidents and accidents at home.

In this sense, the system is directed to all kind of companies, especially medium or big companies.

In Europe, we can estimate about 170.000 medium companies and 40.000 Big Companies.

In Italy there are more than 19.000 Medium enterprises and about 3.000 Big companies.

Starting from these data, we can estimate that the potential market for the R&S result will be about 1%.

 

 

 

6

Evaluation of financial Risks for R&D result
The project has not particular financial risks.

 

 

 

 

SECTION 3: IDENTIFICATION OF FINANCING SOURCES

After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)

 

  1. 1.  European Funding

Define relevance of the product with the following potential funding sources and comment

Note: INTERVALUE partners are expected to pre-define a list of existing European funding sources for product development available for the country and advisors will check whether the proposed product is relevant for that funding source or may define an additional source

1. …FP7

2. …FP8

3.

4.

2      National Funding

Note: INTERVALUE partners are expected to pre-define a list of existing national funding sources for product development available for the country and advisors will check whether the proposed product is relevant for that funding source or may define an additional source

1. … LR 26/2005 (Friuli Venezia Giulia regional law on innovation)

2.

3.

3      Private funding

Note: INTERVALUE partners are expected to pre-define a list of existing private funding sources for product development available for the country and advisors will check whether the proposed product is relevant for that funding source or may define an additional source

1. …Business angels and venture capitalists.

2. …Private capital

3.

4      Other

 

 

 

SECTION 3: FINAL EVALUATION

It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)…
AVIRES Lab team has years of experience in the field of Computer Vision and the Sound and Music Computing and in particular of Active Vision, Audio Digital Library, Auditory Display, Nonverbal Human-Machine Interaction. It knows approximately the market and competitors.

The team should invest time in the proposed project development in order to test the system and to better define the economic and financial feasibility, and the opportunity of a partnership with cameras installers/producers.

Moreover it should be strategic a prior-case assessment in order to evaluate the protection needs.

 

 

 

Decision of evaluation (Please tick  as appropriate)

 

The R&D has a high potential of exploitation

þ

The R&D result needs minor revisions
The R&D result needs moderate revisions
The R&D result needs major revisions
The R&D result has no potential of exploitation

 

 

Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project